PremiumCompany AnnouncementsCynata Therapeutics Forms New Scientific Advisory Board to Enhance R&D Strategy Cynata’s Cymerus™ MSCs Show Promise in Heart Disease Treatment Cynata Therapeutics Updates Director’s Interest Notice PremiumCompany AnnouncementsCynata Therapeutics Director Updates Securities Holdings Cynata Therapeutics Issues New Securities to Boost Market Position Cynata Therapeutics to Host Investor Webinar on Clinical Advancements PremiumCompany AnnouncementsCynata Therapeutics Issues Shares to Directors Post-Approval Cynata Therapeutics Expands Market Presence with New Securities Quotation Cynata Therapeutics Successfully Concludes Extraordinary General Meeting